Literature DB >> 31019770

Perioperative change in neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor in patients with completely resected primary pulmonary sarcomatoid carcinoma.

Yong Won Seong1, Sung Joon Han1, Woohyun Jung1, Jae Hyun Jeon1, Sukki Cho1, Sanghoon Jheon1, Kwhanmien Kim1.   

Abstract

BACKGROUND: There has been controversy regarding prognostic factors for surgically resected primary pulmonary sarcomatoid carcinoma (PSC). Recently, several studies have shown that neutrophil-to-lymphocyte ratio (NLR) was a prognostic factor for various types of cancers from multiple organs. Therefore, we performed this study to evaluate whether NLR is related to prognosis after complete surgical resection of primary PSC.
METHODS: From Oct. 2003 to Sep. 2015, a total of 50 patients underwent surgical resection for primary PSC. After excluding patients with any history of other malignancy and incompletely resected cases, a total of 37 patients were included, and data were retrospectively collected and analyzed. Change in postoperative NLR and the initial NLR (ΔNLR) was calculated from the perioperative complete blood count (CBC) results.
RESULTS: Mean age of the cohort was 62.2±1.9 years, and 31 patients (83.8%) were male. Twenty patients (54.1%) were revealed as pN0. Overall 5-year survival rate was 50.3%. Seventeen patients (45.9%) had locoregional or distant metastases. Univariate survival analysis revealed age >70, ΔNLR >17 as risk factors for overall survival (P=0.009, 0.005) and disease-free survival (P=0.036, 0.018). Multivariate Cox-regression analysis revealed age >70 and ΔNLR >17 as independent risk factors for overall survival and ΔNLR >17 as the only independent risk factor for the disease-free survival.
CONCLUSIONS: In patients with completely resected primary PSC, perioperative ΔNLR had a significant effect on the overall survival and disease-free survival. Older age was also an independent risk factor for overall survival.

Entities:  

Keywords:  Lung cancer; prognosis

Year:  2019        PMID: 31019770      PMCID: PMC6462731          DOI: 10.21037/jtd.2019.02.02

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  29 in total

1.  Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.

Authors:  Basem Azab; Vijaya R Bhatt; Jaya Phookan; Srujitha Murukutla; Nina Kohn; Terenig Terjanian; Warren D Widmann
Journal:  Ann Surg Oncol       Date:  2011-06-03       Impact factor: 5.344

2.  Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

Authors:  Xin An; Pei-Rong Ding; Yu-Hong Li; Feng-Hua Wang; Yan-Xia Shi; Zhi-Qiang Wang; You-Jian He; Rui-Hua Xu; Wen-Qi Jiang
Journal:  Biomarkers       Date:  2010-09       Impact factor: 2.658

3.  Maximally selected chi-square statistics for ordinal variables.

Authors:  Anne-Laure Boulesteix
Journal:  Biom J       Date:  2006-06       Impact factor: 2.207

Review 4.  Neutrophils: key mediators of tumour angiogenesis.

Authors:  Simon Tazzyman; Claire E Lewis; Craig Murdoch
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

5.  Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma.

Authors:  Y L Chang; Y C Lee; J Y Shih; C T Wu
Journal:  Lung Cancer       Date:  2001-10       Impact factor: 5.705

6.  High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer.

Authors:  Hideaki Shimada; Nobuhiro Takiguchi; Osamu Kainuma; Hiroaki Soda; Atsushi Ikeda; Akihiro Cho; Akinari Miyazaki; Hisashi Gunji; Hiroshi Yamamoto; Matsuo Nagata
Journal:  Gastric Cancer       Date:  2010-09-05       Impact factor: 7.370

Review 7.  Personal experience in surgical management of pulmonary pleomorphic carcinoma.

Authors:  Federico Raveglia; Maurizio Mezzetti; Tiziana Panigalli; Simone Furia; Luigi Giuliani; Serena Conforti; Stefano Meda
Journal:  Ann Thorac Surg       Date:  2004-11       Impact factor: 4.330

8.  Pleomorphic carcinoma of the lung: a surgical outcome.

Authors:  Tsuyoshi Yuki; Toshiko Sakuma; Chiho Ohbayashi; Masahiro Yoshimura; Noriaki Tsubota; Yutaka Okita; Morihito Okada
Journal:  J Thorac Cardiovasc Surg       Date:  2007-08       Impact factor: 5.209

9.  Clinicopathological investigation of pulmonary pleomorphic carcinoma.

Authors:  Satoshi Yamamoto; Daisuke Hamatake; Takao Ueno; Takao Higuchi; Masahumi Hiratsuka; Takeshi Shiraishi; Akinori Iwasaki; Takayuki Shirakusa
Journal:  Eur J Cardiothorac Surg       Date:  2007-10-17       Impact factor: 4.191

Review 10.  Cancer-related inflammation.

Authors:  Alberto Mantovani; Paola Allavena; Antonio Sica; Frances Balkwill
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

View more
  5 in total

1.  The ımportance of ınflammatory parameters ın predıctıng deep sternal wound ınfectıons after open heart surgery.

Authors:  Kemal Parla; Ahmet Burak Tatli; Arda Aybars Pala; Mehmet Tugrul Goncu
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

2.  Preoperative systemic immune-inflammation index predicts survival and recurrence in patients with resected primary pulmonary sarcomatoid carcinoma.

Authors:  Qingpeng Zeng; Jiagen Li; Nan Sun; Qi Xue; Yushun Gao; Jun Zhao; Yousheng Mao; Juwei Mu; Dali Wang; Shugeng Gao; Jie He
Journal:  Transl Lung Cancer Res       Date:  2021-01

3.  Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer.

Authors:  Jung Hyun Kim; Jae-Hoon Lee; Hye Sun Lee; Su-Jin Shin; Eun Jung Park; Eun-Suk Cho; Seung Hyuk Baik; Kang Young Lee; Jeonghyun Kang
Journal:  J Inflamm Res       Date:  2021-09-07

4.  Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database.

Authors:  Mingjing Chen; Qiao Yang; Zihan Xu; Bangyu Luo; Feng Li; Yongxin Yu; Jianguo Sun
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

Review 5.  First-line albumin-bound paclitaxel/carboplatin plus apatinib in advanced pulmonary sarcomatoid carcinoma: A case series and review of the literature.

Authors:  Feng-Wei Kong; Wei-Min Wang; Lei Liu; Wen-Bin Wu; Xiang Wang; Miao Zhang
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.